Carlsmed (CARL) has priced its initial public offering at $15 per share, offering 6.7 million shares and aiming to raise around $100.5 million in gross proceeds, excluding any underwriters’ option.
Shares will trade on Nasdaq under the ticker “CARL” starting July 23, 2025, with the offering expected to close the following day.
Underwriters have a 30-day option to buy up to 1.005 million additional shares.
Carlsmed is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions.
Shares will trade on Nasdaq under the ticker “CARL” starting July 23, 2025, with the offering expected to close the following day.
Underwriters have a 30-day option to buy up to 1.005 million additional shares.
Carlsmed is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions.
